US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Dermata Therapeutics, Inc.

0.0194

-0.0001-0.51%

Volume:8.46K

Turnover:159.54

Market Cap:- -

PE:0.00

High:0.0195

Open:0.0194

Low:0.0169

Close:0.0195

52wk High:0.0440

52wk Low:0.0102

Shares:- -

Float Shares:- -

Volume Ratio:1.31

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-28.3716

ROE:-203.36%

ROA:-96.45%

PB:0.00

PE(LYR):- -

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Dermata Therapeutics, Inc.

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.dermatarx.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Dermata Therapeutics, Inc., a late-stage medical dermatology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. The company's lead product candidate is DMT310, which has completed Phase IIb clinical trial for treatment of moderate-to-severe acne; and Phase Ib proof of concept (POC) trial for Mild-to-Moderate Psoriasis, as well as is in a Phase 2 clinical trial for treatment of moderate-to-severe rosacea. It is also developing DMT410 that has completed Phase Ib POC trials for the treatment of anxillary hyperhidrosis and aesthetic conditions. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/DRMAW/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DRMAW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DRMAW\",,,,,undefined,":{"symbol":"DRMAW","market":"US","secType":"STK","nameCN":"Dermata Therapeutics, Inc.","latestPrice":0.0194,"timestamp":1770411600000,"preClose":0.0195,"halted":0,"volume":8462,"delay":0,"changeRate":-0.005128205128205097,"floatShares":0,"shares":0,"eps":-28.3716,"marketStatus":"Market Closed","change":-0.0001,"latestTime":"02-06 16:00:00 EST","open":0.0194,"high":0.0195,"low":0.0169,"amount":159.5353,"amplitude":0.133333,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-28.3716,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"listingDate":1628827200000,"exchange":"NASDAQ","adjPreClose":0.0195,"volumeRatio":1.3129965406280604},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DRMAW\",,,,,undefined,":{"symbol":"DRMAW","floatShares":0,"roa":"-96.45%","roe":"-203.36%","lyrEps":0,"volumeRatio":1.3129965406280604,"shares":0,"dividePrice":0,"high":0.0195,"amplitude":0.133333,"preClose":0.0195,"low":0.0169,"week52Low":0.0102,"pbRate":"0.00","week52High":0.044,"institutionHeld":0,"latestPrice":0.0194,"eps":-28.3716,"divideRate":0,"volume":8462,"delay":0,"ttmEps":-28.3716,"open":0.0194,"prevYearClose":0.0241,"prevWeekClose":0.0195,"prevMonthClose":0.0195,"prevQuarterClose":0.0241,"fiveDayClose":0.0195,"twentyDayClose":0.0216,"sixtyDayClose":0.0275},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DRMAW\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DRMAW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DRMAW\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.dermatarx.com","stockEarnings":[{"period":"1week","weight":-0.0051},{"period":"1month","weight":-0.0251},{"period":"3month","weight":-0.331},{"period":"6month","weight":0.0265},{"period":"1year","weight":-0.3468},{"period":"ytd","weight":-0.195}],"compareEarnings":[{"period":"1week","weight":-0.002},{"period":"1month","weight":0.0015},{"period":"3month","weight":0.0293},{"period":"6month","weight":0.0839},{"period":"1year","weight":0.139},{"period":"ytd","weight":0.0128}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Dermata Therapeutics, Inc., a late-stage medical dermatology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. The company's lead product candidate is DMT310, which has completed Phase IIb clinical trial for treatment of moderate-to-severe acne; and Phase Ib proof of concept (POC) trial for Mild-to-Moderate Psoriasis, as well as is in a Phase 2 clinical trial for treatment of moderate-to-severe rosacea. It is also developing DMT410 that has completed Phase Ib POC trials for the treatment of anxillary hyperhidrosis and aesthetic conditions. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":1.166367},{"month":2,"riseRate":0.2,"avgChangeRate":-0.211933},{"month":3,"riseRate":0.25,"avgChangeRate":-0.152877},{"month":4,"riseRate":0,"avgChangeRate":-0.219099},{"month":5,"riseRate":0.25,"avgChangeRate":0.076727},{"month":6,"riseRate":0.75,"avgChangeRate":0.236149},{"month":7,"riseRate":0.25,"avgChangeRate":-0.087839},{"month":8,"riseRate":0.5,"avgChangeRate":-0.045385},{"month":9,"riseRate":0.2,"avgChangeRate":-0.026317},{"month":10,"riseRate":0.6,"avgChangeRate":-0.08071},{"month":11,"riseRate":0.4,"avgChangeRate":0.020406},{"month":12,"riseRate":0.4,"avgChangeRate":-0.069608}],"exchange":"NASDAQ","name":"Dermata Therapeutics, Inc.","nameEN":"Dermata Therapeutics, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"DRMAW\",market:\"US\",,,undefined,":null}}